Barchart.com
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Aeglea Biothera (AGLE)

Aeglea Biothera (AGLE)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
12.01 +0.97 (+8.79%) 11/27/23 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 12.01 unch (unch) -
News & Headlines for Mon, Nov 27th, 2023
Help
Go To:
Aeglea: Q3 Earnings Snapshot AP - Thu Nov 9, 2023

Aeglea: Q3 Earnings Snapshot

AGLE : 12.01 (+8.79%)
Aeglea BioTherapeutics Announces Grants of Inducement Awards PR Newswire - Mon Oct 2, 2023

/PRNewswire/ -- Aeglea BioTherapeutics, Inc. ("Aeglea") (NASDAQ: AGLE), a biotechnology company advancing a pipeline of antibody therapeutics with the...

AGLE : 12.01 (+8.79%)
Aeglea BioTherapeutics to Participate in Upcoming September Conference PR Newswire - Thu Sep 14, 2023

/PRNewswire/ -- Aeglea BioTherapeutics, Inc. ("Aeglea") (Nasdaq: AGLE), a biotechnology company advancing a pipeline of antibody therapeutics with the...

AGLE : 12.01 (+8.79%)
Aeglea BioTherapeutics Announces Reverse Stock Split PR Newswire - Thu Sep 7, 2023

/PRNewswire/ -- Aeglea BioTherapeutics, Inc. ("Aeglea") (Nasdaq: AGLE), a biotechnology company advancing a pipeline of antibody therapeutics with the...

AGLE : 12.01 (+8.79%)
Aeglea BioTherapeutics Expands Executive Leadership Team with Appointment of Industry Veterans Scott Burrows and Heidy Abreu King-Jones PR Newswire - Tue Sep 5, 2023

/PRNewswire/ -- Aeglea BioTherapeutics, Inc. ("Aeglea") (Nasdaq: AGLE), a biotechnology company advancing a pipeline of antibody therapeutics with the...

AGLE : 12.01 (+8.79%)
ARQT : 14.72 (+1.87%)
Aeglea: Q2 Earnings Snapshot AP - Fri Aug 11, 2023

Aeglea: Q2 Earnings Snapshot

AGLE : 12.01 (+8.79%)
Aeglea BioTherapeutics Reports Second Quarter 2023 Financial Results PR Newswire - Fri Aug 11, 2023

/PRNewswire/ -- Aeglea BioTherapeutics, Inc. ("Aeglea" or the "Company") (NASDAQ:AGLE), a biotechnology company advancing a pipeline of antibody therapeutics...

AGLE : 12.01 (+8.79%)
Aeglea BioTherapeutics Announces Sale of Pegzilarginase to Immedica Pharma PR Newswire - Thu Jul 27, 2023

/PRNewswire/ -- Aeglea BioTherapeutics, Inc. ("Aeglea") (NASDAQ:AGLE), a biotechnology company advancing a pipeline of antibody therapeutics with best-in-class...

AGLE : 12.01 (+8.79%)
Aeglea BioTherapeutics Announces Grant of Inducement Awards PR Newswire - Fri Jun 23, 2023

/PRNewswire/ -- Aeglea BioTherapeutics, Inc. ("Aeglea") (NASDAQ: AGLE) today announced that, in connection with the acquisition of Spyre Therapeutics, Inc....

AGLE : 12.01 (+8.79%)
Increased Funding for Pancreatic Cancer Trials & Treatments Rising along with Demand for New Drugs FinancialNewsMedia - Thu Jun 22, 2023

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:POAI),(NASDAQ:AGLE),(NASDAQ:TALS),(NASDAQ:MRTX) EQNX::TICKER_END

ONCY : 0.5833 (+2.95%)
AGLE : 12.01 (+8.79%)
POAI : 1.0900 (+13.86%)
TALS : 2.72 (-0.73%)
ONC.TO : 0.81 (+2.53%)
MRTX : 58.70 (-0.17%)

Barchart Exclusives

1 ‘Strong Buy’ Dividend Stock to Buy for an ‘America First’ World Barchart - 1 hour ago
GE Aerospace is emerging as a top “Strong Buy” dividend stock, with an 11% jump in revenue and a nearly $1 billion investment in U.S. manufacturing. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective
Wed, Apr 30, 2025 5:00 PM UTC
Reserve Your Spot